The new infusion is all cash and brings the total up to $154 million in funding since Ginkgo launched out of Y Combinator less than two years ago — putting it in the top 10 most significant amounts of financing for any YC startup.The money in this round comes from YC s Continuity Fund, Senator Investment Group, Cascade Investment, Baillie Gifford, Viking Global Investors and Allen & Company LLC.Viking Global also led Ginkgo s Series B round.Ginkgo currently makes products for the flavor, fragrance and food industries as well as works with DARPA to produce probiotics that will help U.S. soldiers stave off stomach bugs they might pick up overseas but started looking at expanding to other industries last year.The startup announced in the spring of 2015 it would be buying 100 million base pairs of DNA to help it move into new production areas but has since upped that amount to the 600 million base pairs and will be partnering with Twist Bioscience and Gen9 to supply the synthetic DNA.Ginkgo will also be using some of the cash to finish building Bioworks2, a new, 70,000 square-foot automated facility built to test prototypes of Ginkgo s designer DNA and create those new products in what co-founder Jason Kelly refers to as verticals tech left behind such as nutrition and pharma.
Bérénice Magistretti is a Swiss freelance writer based in San Francisco.She focuses on startups in Saudi Arabia, Switzerland and emerging markets.While the two-square-mile patch of South San Francisco bustles with over 70 biotech firms, including Genentech, Amgen and Exelixis, an equally influential geography has grown along the Lemanic Arc of Switzerland and into the heart of Basel, where pharma giants like Novartis, Actelion and Roche which acquired Genentech in 2009 have their headquarters.In Switzerland, the Health Valley is trying to take advantage of our unique position in micro/nanotechnology coming from a long tradition of watchmaking.bioinformatics, digital therapeutics, cloud biology and computational medicine .Twist Bioscience and its storage of data in synthetic DNA is a good example.
In San Francisco's Mission Bay neighborhood, a 20-minute streetcar ride away from Google's city offices, lies hidden a DNAThat's not an embellishment: Twist Bioscience, a venture-funded startup with investors including Russian billionaire Yuri Milner and Dr. Boris Nikolic, science advisor to Bill Gates, is writing millions of dollars worth of made-to-order
This small silicon plate is covered in custom-made DNA and worth US$1 million to laboratories all over the US.In San Francisco s Mission Bay neighborhood, a 20-minute streetcar ride away from Google s city offices, lies hidden a DNA factory.That s not an embellishment: Twist Bioscience, a venture-funded start-up with investors including Russian billionaire Yuri Milner and Dr. Boris Nikolic, science advisor to Bill Gates, is selling million-dollar silicon slabs, just a few inches in surface area, coated in synthesised DNA.Now, there s even more demand for custom DNA than ever before, as companies like Microsoft start to explore the possibilities of using DNA as a kind of super-intense hard drive to store lots of data even in the event of global apocalypse.Twist Bioscience founders, left to right: Emily Leproust, Bill Banyai, Bill Peck.Twist CEO Emily Leproust, PhD, is very careful to say that while Twist didn t invent the process of writing custom DNA, they re applying a Silicon Valley mindset to making the process cheaper, easier, and more flexible than ever before.
Do you know — 1 Gram of DNA Can Store 1,000,000,000 Terabyte of Data for 1000 Years.Just last year, Microsoft purchased 10 Million strands of synthetic DNA from San Francisco DNA synthesis startup called Twist Bioscience and collaborated with researchers from the University of Washington to focus on using DNA as a data storage medium.However, in the latest experiments, a pair of researchers from Columbia University and the New York Genome Center (NYGC) have come up with a new technique to store massive amounts of data on DNA, and the results are marvelous.The duo successfully stored 214 petabytes of data per gram of DNA, encoding a total number of six files, which include:A full computer operating systemAn 1895 French movie "Arrival of a Train at La Ciotat"A $50 Amazon gift cardA computer virusA Pioneer plaqueA 1948 study by information theorist Claude ShannonThe new research, which comes courtesy of Yaniv Erlich and Dina Zielinski, has been published in the journal Science.But How Did the Researchers Store Digital Data on DNA?Calling their process a "DNA Fountain," the researchers first compressed all the data into a single master archive and split it into short strings of binary digits, made up of ones and zeros.Next, the duo used an "erasure-correcting algorithm called fountain codes" to randomly packaged the strings into droplets.Each droplet contains a barcode in the sequence that helped the researchers reassembling the file.The researchers then "mapped the ones and zeros in each droplet to the four nucleotide bases in DNA: A, G, C and T," and ended up with a digital list of 72,000 DNA strands that contained the encoded data.This code was then sent in a text file to Twist Biosciences, the same DNA synthesis startup from which Microsoft purchased 10 Million strands of synthetic DNA last year, that then turned that digital information into biological DNA.
Microsoft is buying another ten million strands of DNA to use as part of research into new ways of storing digital data.The long-chain oligonucleotide strands of DNA will be used by researchers at Microsoft and the University of Washington to encode digital data at high density.DNA's main job, of course, is storing the genetic instructions governing the growth and development of all known living creatures -- something it has done for billions of years.Microsoft made its initial purchase of DNA from Twist Bioscience a year ago, buying 10 million strands of synthetic DNA.Since then the organizations have improved storage density, reducing the cost of DNA digital data storage, by encoding more data per strand: in July last year the Microsoft and Washington researchers said they had stored a record 200 megabytes of data on DNA in a space the size of a pencil tip."Importantly, not only does DNA provide a high density, very long-term solution to digital data storage, it requires very little energy at rest compared to today's storage technologies," said Luis Ceze, Ph.D., the University of Washington's Torode Family Career Development Professor of computer science and engineering, and also one of the project's lead researchers.
Last year, Microsoft invested in 10 million strings with synthetic DNA from the firm Twist Bioscience, the in the hope to develop an effective technology to store the data in strings.Now, the reports site Zdnet, Microsoft has decided to buy a further 10 million strings to the project.Since Microsoft's first DNA-purchasing says the company will have developed a more efficient technique to store the data in strings, among other things, the last summer have managed to save 200 megabytes of data on a surface smaller than the tip of a pencil.Read also: Thousands of billions of gigabytes of data can be stored in the DNA - but it cost a fortuneAt the present time is the DNA storage is a very time-consuming and expensive method, but if the barriers, the researchers think that the technology can become widely used.Especially when the storage area can hold up to 2 000 years, but to degrade and to a exabyte can be stored in only a few grams.
Microsoft sign on a building in Cambridge, Massachusetts (Photo credit: DOMINICK REUTER/AFP/Getty Images)Microsoft Monday is a weekly column that focuses on updates in regards to the Redmond giant.This week, Microsoft Monday includes details about IoT Central, a new solution for passwords, the purchase of 10 million DNA strands, the acquisition of Intentional Software, the release of the To-Do app, a battery-saving feature coming to Windows and two major Windows updates coming per year, LinkedIn hitting 500 million users and data being integrated into Dynamics 365 for Sales and much more!“The strands of DNA will be long-chain oligonucleotides used by researchers at Microsoft and the University of Washington to encode digital data at higher density,” said Twist Bioscience in a press release.“After working together for over a year, the organizations have improved storage density, thereby reducing the cost of DNA digital data storage by encoding more data per strand and increasing the throughput of DNA production.”About a year ago, Microsoft purchased its first 10 million strands of synthetic DNA from Twist Bioscience.
Successful demo highlights how the very fabric of life itself may be our best available storage option.Remember when the original iPod wowed us with its claims of letting you carry around 100 songs in your pocket?Well, U.S. biotech company Twist Bioscience, working in conjunction with Microsoft Research and the University of Washington, has just gone several orders of magnitude smaller — by encoding music tracks onto individual strands of DNA.The songs chosen for the remarkable demonstration include “Tutu” by Miles Davis, and a jazz cover of “Smoke on the Water” by Deep Purple.“This is the first time DNA has been used as a long-term archival-quality storage medium,” Angela Bitting, a spokesperson for Twist Bioscience, told Digital Trends.“This is an incredible proof-of-concept project that demonstrates what could happen in a commercial setting, as the price of DNA writing comes down.
According to the new market research report "Synthetic Biology Market by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.Don’t miss out on business opportunities in Synthetic Biology Market  Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology.This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology.The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.Wide range of applications of synthetic biology drives the global synthetic biology marketThe field of medicine has been in the forefront in terms of developing and applying synthetic biology techniques for various applications.Advancements in DNA sequencing and synthesizing technologies have resulted in the better understanding of diseases, aiding the research and discovery of biopharmaceuticals, small molecules, regenerative medicine, and antibody research.Browse and in-depth TOC on "Synthetic Biology Market" 121 - Tables32 - Figures214 - Pages Get Free 10% customization: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services.Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).To know about the assumptions considered for the study, download the pdf brochureMajor Market Developments:In 2017, Thermo Fisher (US) collaborated with AstraZeneca (US) and offered its CRISPR technology to AstraZeneca’s entire drug discovery platform.
Global Synthetic Biology Market report published by Accurize Market Research forecast that the global market is expected to reach $15 billion by 2025; growing at a CAGR of 26% from 2017 to 2025.By geography, the Asia Pacific and North America are expected to grow at a CAGR of XX% and XX%, respectively, during the forecast period.Request Sample: https://www.accurizemarketresearch.com/report/global-synthetic-biology-market/sample-requestAdvancements in DNA sequencing and synthesizing technologies, emerging and spreading synthetic biology techniques for various applications to drive the global marketAdvancements in DNA sequencing and synthesizing technologies, emerging and spreading synthetic biology techniques for various applications drives the growth of the global synthetic biology market.Moreover, Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology and technological innovations also might provide growth opportunities.Market SegmentationThe global synthetic biology market is split into technology, application, industry, and geography.By technology, the market is bifurcated into enabling technologies and biologic components and integrated systems technologies.Application is segmented into enabling technologies and biologic components and integrated systems technologies.Industries categorized into an industrial biotechnology value chain, industry structural forces, and others.Request Customization: https://www.accurizemarketresearch.com/report/global-synthetic-biology-market/ask-for-customizationNorth America, Europe, Asia-Pacific and Rest of the world (RoW) are the geographical segments of the market.Top players in the marketMajor companies operating in the market include Thermo Fisher, Novozymes, Merck KGaA, Intrexon, and Agilent Technologies, Amyris, GenScript, Ginkgo Bioworks, Integrated DNA Technologies, New England Biolabs, Synthetic Genomics, and Twist Bioscience among others. 
In this report, the market is segmented by tool, technology, application, and region.On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.The chassis organisms segment is expected to grow at the highest rate during the forecast period.The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.Browse and in-depth TOC on “Synthetic Biology Market”162 - Tables32 - Figures214 - PagesGet Bundle Reports @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.htmlAccording to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.Early buyers will receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889By application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) applications.The biofuel and renewable energy segment is estimated to grow at the highest CAGR during the forecast period.This high growth rate is attributed to the rising popularity of biofuels and the advantages of using genetically engineered organisms for the synthetic production of biofuels.Key players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).
 In this report, the market is segmented by tool, technology, application, and region.On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.The chassis organisms segment is expected to grow at the highest rate during the forecast period.The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.Browse and in-depth TOC on “Synthetic Biology Market”162 - Tables32 - Figures214 - PagesGet Bundle Reports @ https://www.marketsandmarkets.com/Market-Reports/synthetic-biology-market-889.htmlAccording to the new market research report “Synthetic Biology Market” by Tool (Oligonucleotides, Chassis Organisms, Enzymes), Technology (Genome Engineering, NGS, Cloning and Sequencing), Application (Medical (Pharmaceutical, Drug Discovery), Industrial (Renewable Energy)) - Global Forecast to 2022", published by MarketsandMarkets™, The synthetic biology market is expected to reach USD 8.84 Billion by 2022 from an estimated USD 3.57 Billion in 2017, at a CAGR of 19.9%.Early buyers will receive 10% customization on reports @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=889By application, the synthetic biology market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) applications.The biofuel and renewable energy segment is estimated to grow at the highest CAGR during the forecast period.This high growth rate is attributed to the rising popularity of biofuels and the advantages of using genetically engineered organisms for the synthetic production of biofuels.Key players in the global synthetic biology market include Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).
Oligonucleotides Synthesis Market report provides complete background analysis of the Healthcare IT industry which includes an assessment of the parental market.By thinking from customer point of view, a team of researchers, analysts and industry experts work carefully to generate this Oligonucleotides Synthesis Market research report.A high quality global market research is brought together for the success of your business at international level.Competitor analysis is one of the most important aspects of market research report which helps businesses decide upon the strategies by comparing them with the competitors.Besides, this Oligonucleotides Synthesis Market research report makes clients aware about the various strategies that are used by key players of the market.Global oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.Request Sample Report at @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-synthesis-marketTop Manufacturers Covered in the Report:Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Product LaunchIn April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing.This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases.
A new research study from “Data Bridge Market Research”  with title Oligonucleotides Synthesis Market Insights 2019, Global  Analysis and Forecast to 2026 provides an in-depth assessment of the Women’s Health including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles and strategies.Key players profiled in this report are: Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), DanaherGlobal oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.Request Sample Report at @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-synthesis-marketSegmentation: Global Oligonucleotides Synthesis MarketGlobal Oligonucleotides Synthesis Market By Product Type (DNA Oligonucleotides, RNA Oligonucleotides)Type (Oligonucleotide-Based Drugs, Primers, Probes, Intermediate-Scale Synthesized Oligos, Large-Scale Synthesized Oligos, Linkers & Adaptors, Array-Based Oligos)Consumables (Instruments, Kits & Reagents, Others)Service Type (Custom Oligos, Predesigned Oligos, Oligo Synthesis)Application (Research Applications, Therapeutic Applications, Diagnostic Applications, Others)End User (Biopharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Hospitals, Others)Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa) – Industry Trends and Forecast to 2026Product LaunchIn April 2019, GenScript launched single-stranded DNA service for the CRISPR based gene editing.This would help the researchers to accelerate the advancement of cell therapy, gene therapy as well as the transgenic animal models for the cancer research and treatments.In September 2018, Kaneka Eurogentec S.A. had introduced Therapeutic Oligonucleotides for early clinical phases.With this there is an increased production of clinical and pre-clinical Oligonucleotides.Have Any Query?Ask Our Experts @ https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=global-oligonucleotide-synthesis-marketTop Manufacturers Covered in the Report:Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Some of the key questions answered in this report:Detailed Overview of Oligonucleotides Synthesis Market helps deliver clients and businesses making strategies.Influential factors that are thriving demand and constraints in the market.What is the market concentration?Is it fragmented or highly concentrated?What trends, challenges and barriers will impact the development and sizing of Oligonucleotides Synthesis Market?SWOT Analysis of each key players mentioned along with its company profile with the help of Porter’s five forces tool mechanism to compliment the same.What growth momentum or acceleration market carries during the forecast period?Reasons to Purchase this ReportCurrent and future of Global Oligonucleotides Synthesis Market outlook in the developed and emerging marketsThe segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast periodRegions/Countries that are expected to witness the fastest growth rates during the forecast periodThe latest developments, market shares, and strategies that are employed by the major market playersBrowse Full Report at https://www.databridgemarketresearch.com/reports/global-oligonucleotide-synthesis-marketAbout Us: Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.
Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-synthesis-marketGlobal oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.The oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures.Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.Segmentation: Global Oligonucleotides Synthesis MarketGlobal oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.In March 2015, TriLink BioTechnologies, LLC introduced their new technology Clean Tag which is designed to provide efficiency in the NGS library preparation.The technology is designed for the clinical research purpose that helps in eliminating the gel purification process and advances the work flow method.The introduction of the new technology helping the researchers in NGS library and enhancing the advanced product offering of the company.On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.In September 2018, Maravai LifeSciences (U.S.) announced the lease of new facility to expand the business of lifescience sector for TriLink BioTechnologies, LLC in San Diego, U.S.The new facility will help the company to make the business position globally and helps for the continuous growth in the life science market.On the basis of consumables, the market is segmented into instruments, kits & reagents and others.In May 2019, QIAGEN announced launch of PIK3CA RGQ PCR kit to improve the health of patient with breast cancer.This uses plasma specimens during liquid biopsy.
Synthesized oligonucleotides are used for various applications in the life science and medical industry for research purposes as a probe for DNA synthesis and sequencing, probes for the detection of complementary RNA and DNA through hybridization in clinical developments and synthesis of artificial genes.Global oligonucleotides synthesis market is projected to register a substantial CAGR of 9.3% in the forecast period of 2019 to 2026.Some of the major players operating in this market are Agilent Technologies, Inc., Atdbio Ltd., LGC Limited, Bio-Synthesis Inc., Eurofins Genomics, Kaneka Eurogentec S.A., General Electric, Genscript, AJINOMOTO CO.,INC (Genedesign, Inc.), Danaher, Merck Kgaa, Lgc Biosearch Technologies, Nitto Denko, Thermo Fisher Scientific, Trilink Biotechnologies, Llc, Biolytic Lab Performance Inc., Polygen Gmbh, Quintara Biosciences, Bio Basic Inc., Danaher (Integrated Dna Technologies, Inc.), and Twist Bioscience among others.Get Sample Analysis of Global Market Information: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-oligonucleotide-synthesis-marketThe oligo nucleotides services provided by the manufacturers are available based on the customer requirement which helps in the identification of specific genes in life science research procedures.Various types of fragment oligo nucleotides are available which are prepared and used by different sectors such as for research of life science, the oligos are used as PCR primers and probes, DNA sequencing, gene editing (CRISPR), for the diagnostics applications, the oligos are used as microarrays/gene panels, fluorescence in situ hybridization and for therapeutic applications, the oligo nucleotides are used as nucleic acid aptamers, antisense, gene and cell therapy and others.The wide range of applications in the field of research, diagnostics, therapeutics, drug discovery, data storage and synthetic biology and growing research oriented programs are boosting the requirement of the oligonucleotide in medical sector.The overall market of synthesized oligonucleotides is growing tremendously due to high growth in the life science industries and growing applications in therapeutics and in genetics and genomics in the research and diagnostics.Segmentation: Global Oligonucleotides Synthesis MarketGlobal oligonucleotides synthesis market is segmented into six notable segments which are product type, type, consumables, service type, application and end user.On the basis of product type, the market is segmented into DNA Oligonucleotides and RNA Oligonucleotides.In March 2015, TriLink BioTechnologies, LLC introduced their new technology Clean Tag which is designed to provide efficiency in the NGS library preparation.The technology is designed for the clinical research purpose that helps in eliminating the gel purification process and advances the work flow method.The introduction of the new technology helping the researchers in NGS library and enhancing the advanced product offering of the company.On the basis of type, the market is segmented into oligonucleotide-based drugs, primers, probes, intermediate-scale synthesized oligos, large-scale synthesized oligos, linkers & adaptors and array-based oligos.In September 2018, Maravai LifeSciences (U.S.) announced the lease of new facility to expand the business of lifescience sector for TriLink BioTechnologies, LLC in San Diego, U.S.The new facility will help the company to make the business position globally and helps for the continuous growth in the life science market.On the basis of consumables, the market is segmented into instruments, kits & reagents and others.In May 2019, QIAGEN announced launch of PIK3CA RGQ PCR kit to improve the health of patient with breast cancer.This uses plasma specimens during liquid biopsy.
Synthetic Biology market Overview Synthetic Biology Market Report offers an industry-wide analysis of the market, including precise assessment of the demand for the Synthetic Biology Market and accurate market insights that allow readers to identify the existing opportunities and threats and optimize their investments. It offers the global sector across key regional markets and gives an extensive investigation and statistical analysis of vital market elements. The study also performs an elaborate industry-wide competitive analysis, highlighting the major companies in the Synthetic Biology Market that regulate a substantial portion of the global market share and infers beneficial prospects and hurdles to help the reader invest wisely. It also includes an extensive investigation on Synthetic Biology manufacturers, the expansion strategies adopted by the companies to capitalize on the existing growth prospects, the financial standing, and the individual market share of the leading participants, providing the readers a comprehensive overview of the competitive scenario. To get a PDF Sample Copy (including TOC, Table of content, and facts and figures) of the Synthetic Biology market report, [email protected] https://www.reportsanddata.com/sample-enquiry-form/1476 The following manufacturers have been studied in this report by assessing the sales, gross revenue, and market share for each company: Thermo Fisher, Merck KGaA, Novozymes, DNA2.0, Eurofins Scientific, Inc., Intrexon, Agilent Technologies, Amyris, Pareto Biotechnologies, GenScript, Integrated DNA Technologies, Ginkgo Bioworks, Synthetic Genomics, New England Biolabs, TeselaGen, Twist Bioscience. The information relating to the Synthetic Biology market that has been collected and analyzed in the report will allow a brand engaged in the sector to get the upper hand against leading players in the global landscape.
The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services.Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology.This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Additionally, the reduction in costs per raw megabase of DNA sequencing and a drastic reduction in the cost of synthetic genes is expected to propel the market growth of synthetic biology.The base year considered for the study is 2016, and the forecast has been provided for the period between 2017 and 2022.Global Synthetic Biology Market Segmentation:In this report, the market is segmented by tool, technology, application, and region.On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.The chassis organisms segment is expected to grow at the highest rate during the forecast period.
The global synthetic biology market is expected to grow from USD 3.57 billion in 2017 to USD 8.84 billion by 2022, at a CAGR of 19.9% from 2017 to 2022.Synthetic biology has an array of applications in the fields of medicine, agriculture, nanotechnology, and industrial biotechnology.This has attracted interests of researchers from across the globe and has led to a rise in funding from public and private organizations, which, in turn, help in the growth of the market.Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=889The synthetic biology market comprises a network of players involved in the research and product development; raw material supply; component manufacturing; distribution and sale; and post-sales services.Key players considered in the analysis of the global market are Thermo Fisher (US), Novozymes (Denmark), Merck KGaA (Germany), Intrexon (US), and Agilent Technologies (US), Amyris (US), GenScript (US), Ginkgo Bioworks (US), Integrated DNA Technologies (US), New England Biolabs (US), Synthetic Genomics (US), and Twist Bioscience (US).Get Expert Analysis and Insights of Global Market | Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=889Global Synthetic Biology Market Segmentation:In this report, the market is segmented by tool, technology, application, and region.On the basis tool, the synthetic biology market is segmented into oligonucleotides, enzymes, cloning technology kits, chassis organisms, and xeno-nucleic acids.The chassis organisms segment is expected to grow at the highest rate during the forecast period.The increasing demand for green alternatives (biomass is converted to chemicals using engineered bacteria, yeasts, and other microorganisms) to fossil fuels is a key driver for this segment.By technology, the market is segmented into gene synthesis, genome engineering, cloning and sequencing, next-generation sequencing, site-directed mutagenesis, measurement and modeling, microfluidics, and nanotechnology.In 2017, the gene synthesis segment is expected to account for the largest share of the market in technology.The market is segmented into medical (pharmaceutical, drug discovery & therapeutics, and artificial tissue and tissue regeneration), industrial (biofuel & renewable energy, industrial enzymes, and biomaterials & green chemicals), food & agriculture, and environmental (bioremediation and biosensing) on the basis of application.Speak to Analyst @https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=889
More

Top